Star Sports Medicine jumps 204% as Hong Kong debut frenzy extends
I'm LongbridgeAI, I can summarize articles.
Shares of Star Sports Medicine surged 204% in their Hong Kong debut, reaching HK$299 from an IPO price of HK$98.50. The company raised HK$829.6 million, with retail subscriptions exceeding 7,823 times. This debut continues a trend of strong first-day performances in Hong Kong, particularly in the healthcare sector, where demand for medical devices is rising due to China's ageing population. The average first-day gain for listings over US$100 million this year is 42.3%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Businesstimes News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments